These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12973703)

  • 1. Gene interventions in the beta-adrenergic system for treating heart failure.
    Parsa CJ; Koch WJ
    Semin Thorac Cardiovasc Surg; 2003 Jul; 15(3):259-67. PubMed ID: 12973703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy.
    Pleger ST; Boucher M; Most P; Koch WJ
    J Card Fail; 2007 Jun; 13(5):401-14. PubMed ID: 17602988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic manipulation of beta-adrenergic signalling in heart failure.
    Davidson MJ; Koch WJ
    Acta Physiol Scand; 2001 Sep; 173(1):145-50. PubMed ID: 11678737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model-specific selection of molecular targets for heart failure gene therapy.
    Katz MG; Fargnoli AS; Tomasulo CE; Pritchette LA; Bridges CR
    J Gene Med; 2011 Oct; 13(10):573-86. PubMed ID: 21954055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure.
    Rengo G; Lymperopoulos A; Zincarelli C; Donniacuo M; Soltys S; Rabinowitz JE; Koch WJ
    Circulation; 2009 Jan; 119(1):89-98. PubMed ID: 19103992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular restoration of beta-adrenergic receptor signaling improves contractile function of failing hearts.
    Tevaearai HT; Koch WJ
    Trends Cardiovasc Med; 2004 Aug; 14(6):252-6. PubMed ID: 15451518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial control of the βAR system in heart failure: the transverse tubule and beyond.
    Gorelik J; Wright PT; Lyon AR; Harding SE
    Cardiovasc Res; 2013 May; 98(2):216-24. PubMed ID: 23345264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential future therapies for heart failure: gene transfer of beta-adrenergic signaling components.
    Maurice JP; Koch WJ
    Coron Artery Dis; 1999 Sep; 10(6):401-5. PubMed ID: 10474791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats.
    Anderson KM; Eckhart AD; Willette RN; Koch WJ
    Hypertension; 1999 Jan; 33(1 Pt 2):402-7. PubMed ID: 9931137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization.
    Hata JA; Williams ML; Koch WJ
    J Mol Cell Cardiol; 2004 Jul; 37(1):11-21. PubMed ID: 15242731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.
    Pereira SB; Velloso MW; Chermont S; Quintão MM; Nunes Abdhala R; Giro C; Oliveira E Alves T; Camacho V; De Fátima Maia Contarato L; Pena FM; Balieiro HM; Garcia ML; Da Nóbrega AC; Ribeiro GS; Mesquita ET
    Mol Med Rep; 2013 Jan; 7(1):259-65. PubMed ID: 23064657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for the treatment of heart failure--calcium signaling.
    Bernecker OY; del Monte F; Hajjar RJ
    Semin Thorac Cardiovasc Surg; 2003 Jul; 15(3):268-76. PubMed ID: 12973704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Novel concepts in beta-adrenergic receptor signaling: therapeutic options for heart failure].
    Schiattarella GG; Perrino C; Gargiulo G; Sorrentino S; Franzone A; Capretti G; Esposito G; Chiariello M
    G Ital Cardiol (Rome); 2010 Mar; 11(3):221-8. PubMed ID: 20550062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failure.
    Feldman DS; Carnes CA; Abraham WT; Bristow MR
    Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):475-83. PubMed ID: 16265588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular biology in cardiology. Changes in the phenotype in heart failure and myocardial hypertrophy].
    Böhm M; Wankerl M; Erdmann E
    Internist (Berl); 1994 Feb; 35(2):147-54. PubMed ID: 8150580
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeting GRK2 by gene therapy for heart failure: benefits above β-blockade.
    Reinkober J; Tscheschner H; Pleger ST; Most P; Katus HA; Koch WJ; Raake PW
    Gene Ther; 2012 Jun; 19(6):686-93. PubMed ID: 22336718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy in heart failure.
    Vinge LE; Raake PW; Koch WJ
    Circ Res; 2008 Jun; 102(12):1458-70. PubMed ID: 18566312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beta-adrenergic receptor kinase in heart failure.
    Petrofski JA; Koch WJ
    J Mol Cell Cardiol; 2003 Oct; 35(10):1167-74. PubMed ID: 14519424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer of beta-adrenergic signaling components for heart failure.
    Koch WJ
    J Card Fail; 2002 Dec; 8(6 Suppl):S526-31. PubMed ID: 12555169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function.
    Akhter SA; Eckhart AD; Rockman HA; Shotwell K; Lefkowitz RJ; Koch WJ
    Circulation; 1999 Aug; 100(6):648-53. PubMed ID: 10441103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.